Michael D. Decker

8.6k total citations · 1 hit paper
168 papers, 6.2k citations indexed

About

Michael D. Decker is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Michael D. Decker has authored 168 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Epidemiology, 63 papers in Microbiology and 25 papers in Infectious Diseases. Recurrent topics in Michael D. Decker's work include Bacterial Infections and Vaccines (61 papers), Pneumonia and Respiratory Infections (55 papers) and Influenza Virus Research Studies (31 papers). Michael D. Decker is often cited by papers focused on Bacterial Infections and Vaccines (61 papers), Pneumonia and Respiratory Infections (55 papers) and Influenza Virus Research Studies (31 papers). Michael D. Decker collaborates with scholars based in United States, Switzerland and Canada. Michael D. Decker's co-authors include Kathryn M. Edwards, Janet A. Englund, Wayne A. Ray, Randy L. Fought, Dennis M. Perrotta, David P. Greenberg, Edwin L. Anderson, Michael E. Pichichero, Mark C. Steinhoff and Kathryn M. Edwards and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael D. Decker

163 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

2014 549 citations David P. Greenberg, Michael D. Decker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Decker United States	40	3.9k	2.2k	1.2k	705	498	168	6.2k
William C. Blackwelder United States	48	2.9k 0.8×	1.2k 0.5×	1.7k 1.4×	332 0.5×	682 1.4×	125	8.8k
Edwin Lewis United States	39	5.3k 1.4×	2.3k 1.1×	1.1k 0.9×	1.3k 1.8×	347 0.7×	81	7.1k
Flor M. Muñoz United States	44	3.8k 1.0×	1.2k 0.6×	1.7k 1.4×	1.6k 2.3×	621 1.2×	205	6.8k
Marta Luisa Ciofi degli Atti Italy	35	2.4k 0.6×	1.2k 0.6×	787 0.6×	626 0.9×	211 0.4×	183	4.0k
Juhani Eskola Finland	47	6.1k 1.6×	4.1k 1.9×	1.1k 0.9×	1.1k 1.5×	480 1.0×	132	8.0k
Fiona van der Klis Netherlands	39	2.8k 0.7×	891 0.4×	1.5k 1.2×	706 1.0×	235 0.5×	175	5.4k
Nancy M. Bennett United States	45	8.5k 2.2×	3.3k 1.5×	1.2k 1.0×	744 1.1×	511 1.0×	126	10.4k
Roger Baxter United States	45	4.6k 1.2×	1.9k 0.9×	2.6k 2.1×	1.2k 1.8×	190 0.4×	136	7.1k
S. Michael Marcy United States	38	2.6k 0.7×	1.1k 0.5×	1.2k 1.0×	915 1.3×	789 1.6×	90	5.1k
Maria Deloria Knoll United States	38	6.1k 1.6×	2.8k 1.3×	2.0k 1.6×	1.4k 2.0×	342 0.7×	124	8.6k

Countries citing papers authored by Michael D. Decker

Since Specialization

Citations

This map shows the geographic impact of Michael D. Decker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Decker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Decker more than expected).

Fields of papers citing papers by Michael D. Decker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Decker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Decker. The network helps show where Michael D. Decker may publish in the future.

Co-authorship network of co-authors of Michael D. Decker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Decker. A scholar is included among the top collaborators of Michael D. Decker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Decker. Michael D. Decker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Decker, Michael D., et al.. (2021). Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members. Vaccine. 39(39). 5541–5547. 20 indexed citations

Nautrup, B Poulsen, Ilse Van Vlaenderen, Michael D. Decker, & R.M. Cleale. (2017). Antimicrobial drug use for control and treatment of bovine respiratory disease in US feedlot cattle. The Bovine Practitioner. 1–13. 3 indexed citations

Eltobgy, Mostafa, Hani Oweira, Ulf Petrausch, et al.. (2017). Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Review of Neurotherapeutics. 17(7). 725–736. 17 indexed citations

Abdel‐Rahman, Omar, et al.. (2017). Immune-Related Musculoskeletal Toxicities Among Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review. Immunotherapy. 9(14). 1175–1183. 29 indexed citations

Oweira, Hani, Ulf Petrausch, Daniel Helbling, et al.. (2017). Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis. World Journal of Gastroenterology. 23(10). 1872–1872. 129 indexed citations

Oweira, Hani, Jan Schmidt, Daniel Helbling, et al.. (2017). Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review. Expert Review of Gastroenterology & Hepatology. 11(3). 1–10. 21 indexed citations

Baxter, Roger, John Hansen, Julius Timbol, et al.. (2016). Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine. Human Vaccines & Immunotherapeutics. 12(11). 2742–2748. 4 indexed citations

Robertson, Corwin A., et al.. (2016). Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine. Vaccine. 34(44). 5273–5278. 14 indexed citations

Hardy-Fairbanks, Abbey J, Stephanie Pan, Michael D. Decker, et al.. (2013). Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy. The Pediatric Infectious Disease Journal. 32(11). 1257–1260. 117 indexed citations

10.

Siberry, George K., Meredith G. Warshaw, Paige L. Williams, et al.. (2011). Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in 2- to 10-year-old Human Immunodeficiency Virus-infected Children. The Pediatric Infectious Disease Journal. 31(1). 47–52. 28 indexed citations

11.

Decker, Michael D., et al.. (2000). Help Wanted. Infection Control and Hospital Epidemiology. 21(12). 757–759.

12.

Decker, Michael D. & Kathryn M. Edwards. (1996). The Multicenter Acellular Pertussis Trial: An Overview. The Journal of Infectious Diseases. 174(Supplement 3). S270–S275. 12 indexed citations

13.

Decker, Michael D.. (1995). Respiratory Protection Standard: Comments on OSHA's Proposed Revision. Infection Control and Hospital Epidemiology. 16(6). 365–371. 1 indexed citations

14.

Pichichero, Michael E., Cynthia Christy, Michael D. Decker, et al.. (1995). Defining the Key Parameters for Comparing Reactions Among Acellular and Whole-Cell Pertussis Vaccines. PEDIATRICS. 96(3). 588–592. 20 indexed citations

15.

Englund, Janet A., Edwin L. Anderson, George F. Reed, et al.. (1995). The Effect of Maternal Antibody on the Serologic Response and the Incidence of Adverse Reactions After Primary Immunization With Acellular and Whole-Cell Pertussis Vaccines Combined with Diphtheria and Tetanus Toxoids. PEDIATRICS. 96(3). 580–584. 152 indexed citations

16.

Decker, Michael D., et al.. (1992). The OSHA Bloodborne Hazard Standard. Infection Control and Hospital Epidemiology. 13(7). 407–417. 15 indexed citations

17.

Decker, Michael D. & William E. Scheckler. (1992). Continuous Quality Improvement in a Hospital System: Implications for Hospital Epidemiology. Infection Control and Hospital Epidemiology. 13(5). 288–292. 9 indexed citations

18.

Decker, Michael D.. (1992). The Application of Continuous Quality Improvement to Healthcare. Infection Control and Hospital Epidemiology. 13(4). 226–230. 7 indexed citations

19.

Decker, Michael D.. (1991). The Development of Indicators. Infection Control and Hospital Epidemiology. 12(8). 490–492. 22 indexed citations

20.

Decker, Michael D., et al.. (1990). Natural History of Pertussis Antibody in the Infant and Effect on Vaccine Response. The Journal of Infectious Diseases. 161(3). 487–492. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact